Hydrochloric Acid

Hydrochloric Acid

SCHEMBL553592

[Au+].[Au+].[Au+].[Au+].[Cl-].[Cl-].[Cl-].[Cl-]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL14691308 1.00
Hydrochloric Acid SCHEMBL34802 1.00
Phosphine SCHEMBL12818347 0.82
Hydrochloric Acid SCHEMBL150036 0.82
Hydrochloric Acid SCHEMBL147589 0.82
Methane SCHEMBL23040988 0.82
Hydrochloric Acid SCHEMBL18918410 0.82
Water SCHEMBL545666 0.82
Water SCHEMBL994296 0.82
Water SCHEMBL2197085 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 174 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119770670-A Protein microsphere inhibitor and preparation method and application thereof 西安交通大学医学院第一附属医院 2025-04-08 CN claimed
US-11807915-B2 Concentration of precious metals and rare earth elements LIEN LARRY (US) 2023-11-07 US claimed
CN-116832167-A Construction and application of endoperoxide-based nano oxygen delivery system 大连理工大学 2023-10-03 CN claimed
CN-114272392-B Lipid nano gold particle complex and application thereof in delivery of ERG and treatment of cerebral edema disease 山东第一医科大学第一附属医院(山东省千佛山医院) 2023-10-03 CN claimed
CN-116350802-A Lipid gold nanoparticle composite for treating sepsis and preparation method thereof 山东第一医科大学第一附属医院(山东省千佛山医院) 2023-06-30 CN claimed
CN-115814788-A Noble metal adsorption catalyst, preparation method and application thereof 中国石油化工股份有限公司 2023-03-21 CN claimed
WO-2022125547-A1 CONCENTRATION OF LITHIUM FROM UNCONVENTIONAL WATER SOURCES LIEN LARRY (US) 2022-06-16 WO claimed
CN-114272392-A Lipid nano-gold particle compound and application thereof in delivering ERG and treating cerebral edema diseases 山东省千佛山医院 2022-04-05 CN claimed
CN-113206262-B Preparation method of active-opening hollow-shell type nano Pt microstructure for fuel cell catalysis 太原科技大学 2022-03-18 CN claimed
WO-2022021859-A1 SYNTHESIS METHOD FOR CARISOPRODOL ANTIGEN AND APPLICATION THEREOF 杭州安旭生物科技股份有限公司 2022-02-03 WO claimed
WO-2021257646-A1 CONCENTRATION OF PRECIOUS METALS AND RARE EARTH ELEMENTS LIEN LARRY (US) 2021-12-23 WO claimed
US-20210388464-A1 CONCENTRATION OF PRECIOUS METALS AND RARE EARTH ELEMENTS LIEN LARRY (US) 2021-12-16 US claimed
CN-113206262-A Preparation method of active-opening hollow-shell type nano Pt microstructure for fuel cell catalysis 太原科技大学 2021-08-03 CN claimed
CN-111909257-A Synthesis method and application of carisoprodol antigen 杭州安旭生物科技股份有限公司 2020-11-10 CN claimed
CN-108940384-B Catalyst for soot combustion reaction and preparation method and application thereof 中国石油大学(北京) 2020-06-05 CN claimed
CN-108147457-B Method for preparing bismuth-based oxide nanosheets and application of bismuth-based oxide nanosheets 清华大学 2020-02-21 CN claimed
US-20120141691-A1 METHOD OF APPLYING A METALLIC PRECURSOR TO A TITANIUM OXIDE COATING TO FORM A COMPOSITE COATING OR MATERIAL NATIONAL APPLIED RESEARCH LABORATORIES (TW) 2012-06-07 US claimed
JP-2002541098-A 2002-12-03 JP claimed
EP-1165083-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF PSYCHOTIC AND RELATED DISORDERS USING ZIPRASIDONE METABOLITES Sepracor Inc. (US) 2002-01-02 EP claimed
WO-2000059489-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF PSYCHOTIC AND RELATED DISORDERS USING ZIPRASIDONE METABOLITES SEPRACOR INC. (US) 2000-10-12 WO claimed